Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Personalized Therapy|March 20, 2017
An update on HLA alleles associated with adverse drug reactionsIngrid Fricke-Galindo, Adrián LLerena, Marisol López-López
Archives of Medical Research|November 13, 2012
Genetics of Alzheimer's diseaseMaría Elisa Alonso Vilatela, Marisol López-López, Petra Yescas-Gómez
Expert Review of Clinical Pharmacology|June 15, 2018
Carbamazepine adverse drug reactionsIngrid Fricke-Galindo, Adrián LLerena, Helgi Jung-Cook, et al.
Gaceta Medica De Mexico|March 6, 2015
[Genetic factors associated with dementia in Parkinson's disease (PD)]Diego Romo-Gutiérrez, Petra Yescas, Marisol López-López, et al.
Drug Metabolism and Personalized Therapy|January 27, 2016
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)Ingrid Fricke-Galindo, Helgi Jung-Cook, Adrián LLerena, et al.
Journal of Clinical Medicine|January 11, 2025
Valproic Acid and Lamotrigine Differentially Modulate the Telomere Length in Epilepsy PatientsSalvador Sánchez-Badajos, Alberto Ortega-Vázquez, Marisol López-López, et al.
Life (Basel, Switzerland)|September 27, 2025
Genetic Variants in Cytokines IL-10 and IL-17A Are Associated with the Risk and Severity of Sporadic Parkinson's Disease in Mexican PatientsNancy Monroy-Jaramillo, Alberto Ortega-Vázquez, Marisol López-López, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|January 18, 2020
Aptamers coupled to nanoparticles in the diagnosis and treatment of microbial infectionsJuan Carlos Gutiérrez-Santana, Julia Dolores Toscano-Garibay, Marisol López-López, et al.
Drug Metabolism and Drug Interactions|January 11, 2014
Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical responseNancy Monroy Jaramillo, Ingrid Fricke Galindo, Alberto Ortega Vázquez, et al.
Pageof 4